Abstract:Bacterial infections are still the main significant problem of public health in the world, and their elimination will greatly rely on the discovery of antibacterial drugs. In the processes of our searching for novel macrolide derivatives with excellent activity against sensitive and resistant bacteria, three series of novel N11-, C12- and C13substituted 15-membered homo-aza-clarithromycin derivatives were designed and synthesized as Series A, B and C by creatively opening the lactone ring of clarithromycin (CAM), introducing various 4-substituted phenyl-1H1,2,3-triazole side chains at the N11, C12 or C13 position of CAM and macrolactonization. The results from their in vitro antibacterial activity demonstrated that compounds 20c, 20d and 20f displayed not only the most potent activity against S. aureus ATCC25923 with the MIC values of 0.5, 0.5 and 0.5 & micro;g/mL, but also greatly improved activity against B. subtilis ATCC9372 with the MIC values of less than or equal to 0.25, 0.25 and 0.25 & micro;g/mL, respectively. In particular, compound 11g exhibited the strongest antibacterial effectiveness against all the tested resistant bacterial strains and had well balanced activity with the MIC values of 4-8 & micro;g/mL. Further study on minimum bactericidal concentration and kinetics confirmed that compound 11g possessed a bacteriostatic effect on bacterial proliferation. Moreover, the results of molecular docking revealed an potential additional binding force between compound 11g and U790 in addition to the normal binding force of macrolide skeleton, which may explain why this compound performed the most potent activity against resistant bacteria. The results of cytotoxic assay indicated that compounds 20c, 20d and 20f were non-toxic to human breast cancer MCF-7 cells at its effective antibacterial concentration.

Synthesis and Antibacterial Evaluation of Novel Clarithromycin Derivatives with C-4″ Elongated Arylalkyl Groups Against Macrolide-Resistant Strains.

Novel Clarithromycin Analogs with C-4&#x201D; 2-Arylbenzimidazolyl Bishydrazide Side Chain: Synthesis and Antibacterial Evaluation

Synthesis and antibacterial activity of novel 4″-O-benzimidazolyl clarithromycin derivatives.

Synthesis and Antibacterial Evaluation of Novel 11-O-aralkylcarbamoyl-3-o-descladinosylclarithromycin Derivatives

Synthesis and antibacterial activity of novel 4''-O-arylalkylcarbamoyl and 4''-O-((arylalkylamino)-4-oxo-butyl)carbamoyl clarithromycin derivatives.

Synthesis and Antibacterial Activity of Novel 3-O-carbamoyl Derivatives of Clarithromycin and 11,12-Cyclic Carbonate Azithromycin

Synthesis and Antibacterial Activity of Novel 3-O-arylalkylcarbamoyl-3-o-descladinosyl-9-o-(2-chlorobenzyl)oxime Clarithromycin Derivatives

Synthesis and antibacterial activity of 4″-O-carbamoyl analogs of clarithromycin

Synthesis and Antibacterial Activity of Novel 4"-O-carbamoyl Erythromycin-A Derivatives

Synthesis and Antibacterial Activity of Novel 15-Membered Macrolide Derivatives: 4″-Carbamate, 11,12-Cyclic Carbonate-4″-carbamate and 11,4″-Di-o-arylcarbamoyl Analogs of Azithromycin

Novel C-4″ Modified Azithromycin Analogs with Remarkably Enhanced Activity Against Erythromycin-Resistant Streptococcus Pneumoniae: the Synthesis and Antimicrobial Evaluation

Synthesis and Antibacterial Evaluation of Novel 11-O-carbamoyl Clarithromycin Ketolides

Synthesis and Antibacterial Activity of Novel 4″-O-desosaminyl Clarithromycin Derivatives with 11, 12-Arylalkyl Side Chains

Synthesis and Antibacterial Activity of Novel 4″-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) Azithromycin Analogs.

Synthesis and Antibacterial Activity of 4″,11-Di-o-arylalkylcarbamoyl Azithromycin Derivatives

Synthesis and Antibacterial Evaluation of Novel 11,4″-Disubstituted Azithromycin Analogs with Greatly Improved Activity Against Erythromycin-Resistant Bacteria.

Synthesis and Antibacterial Activity of Novel 3-O-descladinosylazithromycin Derivatives

Synthesis and Antibacterial Activity of Novel 11-O-phenethylcarbamoylazithromycin Derivatives with 4 ''-Elongated Side Chains

Design, Synthesis and Structure–activity Relationships of Novel N11-, C12- and C13-substituted 15-Membered Homo-Aza-clarithromycin Derivatives Against Various Resistant Bacteria

Design, Synthesis and Antibacterial Evaluation of Novel 15-Membered 11A-Azahomoclarithromycin Derivatives with the 1, 2, 3-Triazole Side Chain.

Design, synthesis and antibacterial evaluation of novel C-11, C-9 or C-2'-substituted 3-O-descladinosyl-3-ketoclarithromycin derivatives